drugset / Trial / NCT00005018
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
Treatment
Summary
The purpose of this study is to see if it is safe and effective to give HIV-positive patients a combination of anti-HIV drugs (abacavir \[ABC\] plus efavirenz \[EFV\] plus didanosine \[ddI\]) with and without hydroxyurea (HU).
Timeline
- Start
- 1999-07
- Primary completion
- —
- Completion
- 2000-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | 300 mg | — |
| Subject | Didanosine | Small molecule | 400 mg | — |
| Subject | Efavirenz | Other / unclassified | 600 mg | — |
| Subject | Hydroxyurea | Other / unclassified | 500 mg | — |